BMRA — Biomerica Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro CapNeutral
- $39.68m
- $29.51m
- $7.20m
- 36
- 31
- 46
- 30
Walmart to Begin Selling Biomerica’s Aware® Breast Self Exam
NewsBiomerica to Participate at BTIG Biotech Conference
NewsBiomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect™
NewsBUZZ-Biomerica rises on seeking FDA approval for bacterial infection test
NewsBRIEF-Biomerica Reports FDA Submission For Test to Detect H. pylori
NewsBiomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Approximately 35% of the US Population
NewsBiomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021
NewsBiomerica Inc expected to post a loss of 10 cents a share - Earnings Preview
NewsBRIEF-Biomerica Announces Positive Topline Results From Endpoint Clinical Trial Of Its Infoods IBS Treatment
NewsBiomerica Announces Positive Topline Results from the Endpoint Clinical Trial of its InFoods® IBS Treatment for Patients with Irritable Bowel Syndrome
NewsBRIEF-Biomerica Reports Record Financial Results For Fiscal Second Quarter Ended November 30, 2021
NewsBiomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021
NewsBiomerica Inc reports results for the quarter ended in November - Earnings Summary
NewsBiomerica Inc expected to post a loss of 8 cents a share - Earnings Preview
NewsBUZZ-U.S. STOCKS ON THE MOVE-Adobe, Accenture, Under Armour, Novavax
NewsBRIEF-Biomerica Announces Preliminary Q2 Revenue Increase Of About 238%
NewsBUZZ-Biomerica gains as it sees Q2 revenue more than tripling
NewsBiomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million
NewsBRIEF-Biomerica Inc SEC Has Concluded Its Previously-Disclosed Investigations With No Enforcement Action Recommendations
News